硒制剂在桥本甲状腺炎伴甲状腺功能减退中应用分析.docVIP

硒制剂在桥本甲状腺炎伴甲状腺功能减退中应用分析.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
硒制剂在桥本甲状腺炎伴甲状腺功能减退中应用分析

硒制剂在桥本甲状腺炎伴甲状腺功能减退中应用分析   [摘要] 目的 分析硒制剂在桥本甲状腺炎伴甲状腺功能减退中的应用效果。 方法 整群选取2014年2月―2015年3月该院收治的桥本甲状腺炎伴甲状腺功能减退患者63例,随机分为两组。其中对照组采用传统治疗即口服甲状腺素,观察组在此基础上给予硒制剂治疗。记录两组患者治疗前后的血清游离三碘甲腺原氨酸、游离甲状腺素、促甲状腺激素、白介素2、白介素4变化。 结果 治疗后观察组血清游离三碘甲腺原氨酸[(4.16±0.24)vs(3.87±0.27)]、游离甲状腺素[(14.42±0.89)vs(12.06±1.23)]、白介素4[(1.14±0.11)vs(0.98±0.15)]高于对照组,促甲状腺激素[(4.83±3.24)vs(10.28±5.16)]、白介素2[(3.86±0.37)vs(4.37±0.34)]均低于对照组,差异有统计学意义(P0.05)。 结论 硒制剂可纠正甲状腺功能减退状态,提高桥本甲状腺炎伴甲状腺功能减退患者的临床效果。   [关键词] 硒制剂;桥本甲状腺炎;甲状腺功能减退   [中图分类号] R581 [文献标识码] A [文章编号] 1674-0742(2016)02(a)-0150-02   Application Analysis of Selenium Preparation in the Hashimotos Thyroiditis with Hypothyrea   CHE Wei-juan   Endocrine Department, Daqing Fourth Hospital, Daqing, Heilongjiang Province, 163712 China   [Abstract] Objective To analyze the application effect of selenium preparation in the hashimotos thyroiditis with hypothyrea. Methods 63 cases of patients with hashimotos thyroiditis with hypothyrea treated in our hospital from February 2014 to March 2015 were randomly divided into two groups, the control group were given traditional treatment namely oral administration of thyroid hormone, the observation group were given selenium preparation treatment on this basis, the changes of serum free triiodothyronine, free thyroxine, hormothyrin, interleukin-2 and interleukin-4 of the two groups before and after treatment were recorded. Results After treatment, the serum free triiodothyronine, free thyroxine and interleukin-4 in the observation group were respectively [(4.16±0.24)vs(3.87±0.27)], [(14.42±0.89)vs(12.06±1.23)] and [(1.14±0.11)vs(0.98±0.15)], which were higher than those in the control group, the hormothyrina and interleukin-2 in the observation group were respectively [(4.83±3.24)vs(10.28±5.16)] and [(3.86±0.37)vs(4.37±0.34)], which were lower than those in the control group, and the differences were statistically significant (P0.05). Conclusion Selenium preparation can correct hypothyroidism status and improve the clinical e

文档评论(0)

erterye + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档